No hay productos en el carrito



Severe Asthma (ERS Monographs)
Chung, K. — Israel, E. — Gibson, P.
1ª Edición Septiembre 2016
Inglés
Tapa blanda
300 pags
1000 gr
22 x 28 x 2 cm
ISBN 9781849841030
Editorial European Respiratory Society
LIBRO IMPRESO
-5%
82,90 €78,76 €IVA incluido
79,71 €75,73 €IVA no incluido
Recíbelo en un plazo de
7 - 10 días
1. Definition and impact
2. Understanding the experience of people living with severe asthma
3. The contribution of comorbidities, psychosocial factors and adherence to the presentation of severe asthma
4. Clinical phenotypes: adults
5. Clinical phenotypes: children
6. Mechanisms underlying fixed airflow obstruction and exacerbations
7. Clinical biomarkers and noninvasive assessment
8. Imaging
9. Pathophysiology
10. The lessons from U-BIOPRED
11. SARP: dissecting subphenotypes and endotypes
12. Molecular phenotypes
13. Metabolic dysfunction
14. Corticosteroid responsiveness and resistance
15. Mechanisms in children
16. Evaluation and management in children
17. Evaluation of difficult-to-treat and severe asthma in adults
18. Biologics targeting type 2 inflammation
19. Nonpharmacological interventions: behavioural and interventional approaches
20. Management in adults
21. The next decade of continuing progress
We are experiencing delays in shipping to some European countries owing to ongoing strike action in France. We are currently unable to guarantee delivery times. We apologise for any inconvenience this may cause you.
Edited by Kian Fan Chung, Elliot Israel and Peter G. Gibson
Severe asthma is a form of asthma that responds poorly to currently available medication, and its patients represent those with greatest unmet needs. In the last 10 years, substantial progress has been made in terms of understanding some of the mechanisms that drive severe asthma; there have also been concomitant advances in the recognition of specific molecular phenotypes. This ERS Monograph covers all aspects of severe asthma epidemiology, diagnosis, mechanisms, treatment and management but has a particular focus on recent understanding of mechanistic heterogeneity based on an analytic approach using various 'omics platforms applied to clinically well-defined asthma cohorts. How these advances have led to improved management targets is also emphasised. This book brings together the clinical and scientific expertise of those from around the world who are collaborating to solve the problem of severe asthma.
This book contains a unique code that gives you free access to the eBook. CODE. This book also includes clinical cases.
© 2025 Axón Librería S.L.
2.149.0